Clinical Trial Update: Efficacy and Safety of Toripalimab Combined With AP-induced Chemotherapy Followed in Non-metastatic IVB Hypopharyngeal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating toripalimab with AP-induced chemotherapy in non-metastatic stage IVB hypopharyngeal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypopharyngeal Cancer

Drugs mentioned

• AP-induced chemotherapy
• Toripalimab (Toripalimab)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Hypopharyngeal Cancer | Phase 2 | Status: UNKNOWN